Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Feb 27, 2025; 17(2): 99529
Published online Feb 27, 2025. doi: 10.4240/wjgs.v17.i2.99529
Published online Feb 27, 2025. doi: 10.4240/wjgs.v17.i2.99529
Table 1 Baseline data of the enrolled patients
Characteristics | Total (n = 248) | Training (n = 164) | Validation (n = 84) | P value |
Gender, (male vs female) | 204/44 | 139/25 | 65/19 | 0.150 |
Body weight, kg | 65.00 (60.00, 71.00) | 64.50 (60.00, 70.00) | 66.00 (60.00, 73.50) | 0.344 |
Hypertension, (yes, no) | 48/199 | 34/129 | 14/70 | 0.430 |
Diabetes mellitus, (yes, no) | 28/219 | 21/142 | 7/77 | 0.285 |
PT, second | 11.80 (11.28, 12.70) | 11.95 (11.30, 12.80) | 11.80 (11.20, 12.40) | 0.111 |
INR | 1.04 (0.98, 1.11) | 1.04 (0.97, 1.10) | 1.06 (1.01, 1.11) | 0.063 |
ALT, U/L | 36.00 (24.75, 51.25) | 37.00 (24.00, 51.25) | 35.00 (26.00, 49.25) | 0.798 |
ALB, g/L | 41.06 ± 4.07 | 41.32 ± 4.06 | 40.55 ± 4.04 | 0.158 |
TBil, μmol/L | 15.68 (12.21, 20.30) | 15.52 (12.50, 20.64) | 15.85 (11.80, 19.22) | 0.885 |
DBil, μmol/L | 5.12 (3.47, 7.04) | 4.37 (3.13, 6.06) | 6.44 (5.43, 8.33) | < 0.001 |
GGT, U/L | 49.00 (30.00, 77.00) | 46.50 (29.00, 75.25) | 50.00 (33.25, 77.25) | 0.41 |
ALP, U/L | 83.00 (67.75, 111.00) | 86.00 (70.00, 109.00) | 78.50 (64.00, 114.25) | 0.369 |
Cr, μmol/L | 62.00 (54.77, 71.12) | 61.60 (54.65, 71.62) | 63.05 (54.98, 69.47) | 0.95 |
PLT, 109/L | 126.00 (86.75, 171.00) | 125.00 (82.50, 168.25) | 128.50 (96.50, 175.50) | 0.171 |
Lymphocyte, 109/L | 1.28 (0.94, 1.63) | 1.23 (0.86, 1.61) | 1.32 (1.08, 1.64) | 0.046 |
Monocyte, 109/L | 0.39 (0.28, 0.47) | 0.36 (0.27, 0.45) | 0.42 (0.30, 0.52) | 0.008 |
Neutrophil, 109/L | 2.78 (2.09, 3.55) | 2.65 (2.01, 3.48) | 2.96 (2.20, 3.95) | 0.132 |
NLR | 2.21 (1.62, 3.19) | 2.24 (1.68, 3.20) | 2.15 (1.51, 3.00) | 0.427 |
PLR | 101.95 (75.32, 134.54) | 102.65 (78.24, 136.89) | 98.40 (72.94, 125.26) | 0.344 |
PVD, mm | 15.00 (14.00, 16.05) | 15.00 (13.30, 17.00) | 15.00 (14.00, 16.00) | 0.337 |
Number of tumors, ≥ 2/1 | 26/222 | 15/149 | 11/73 | 0.337 |
ALBI score | -2.70 ± 0.34 | -2.72 ± 0.34 | -2.65 ± 0.34 | 0.119 |
APRI score | 0.68 (0.48, 1.30) | 0.76 (0.49, 1.30) | 0.62 (0.44, 1.20) | 0.161 |
MELD score | 56.87 ± 3.14 | 56.78 ± 2.82 | 57.05 ± 3.70 | 0.519 |
PALBI score | -2.61 (-2.74, -2.44) | -2.61 (-2.75, -2.48) | -2.58 (-2.73, -2.41) | 0.144 |
PHLF, no/yes | 161/87 | 109/55 | 52/32 | 0.476 |
- Citation: Sun K, Li JB, Chen YF, Zhai ZJ, Chen L, Dong R. Predicting post-hepatectomy liver failure using a nomogram based on portal vein width, inflammatory indices, and the albumin-bilirubin score. World J Gastrointest Surg 2025; 17(2): 99529
- URL: https://www.wjgnet.com/1948-9366/full/v17/i2/99529.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i2.99529